Note: Revenues for privately held companies are statistical evaluations.
Medimetriks Pharmaceuticals's annual revenues are $50-$100 million (see exact revenue data) and has 10-100 employees. It is classified as operating in the Drugs & Druggists' Sundries Merchant Wholesalers industry.
Note: Medimetriks Pharmaceuticals's revenues are gauged from an analysis of company filings.
Medimetriks Pharmaceuticals's Income Statement (based on Industry Averages)
$ Millions (Industry Average)
Medimetriks Pharmaceuticals Revenue (Sales)
Cost of Goods Sold
Salaries and wages
Other Operating Expenses
Total Operating Expenses
EBIT (Earnings Before Interest and Taxes)
Trademark applications show the products and services that Medimetriks Pharmaceuticals is developing and marketing.
Medimetriks Pharmaceuticals's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets.
Trademarks may include brand names, product names, logos and slogans.
RURSAS Pharmaceutical preparation for dermatologic use in treating skin disorders
BEISEN Pharmaceutical preparation for dermatologic use in treating skin disorders
QUILASTA Pharmaceutical preparation for dermatologic use in treating skin disorders
Determine whether Medimetriks Pharmaceuticals grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof Medimetriks Pharmaceuticals is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
Market Share of Medimetriks Pharmaceuticals's Largest Competitors
A competitive analysis shows these companies are in the same general field as Medimetriks Pharmaceuticals, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Medimetriks Pharmaceuticals.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Medimetriks Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.